CODX Co-Diagnostics Inc.

Co-Diagnostics Inc is a molecular diagnostics company that has developed, and intends to sell molecular diagnostic technology such as lab systems and manufacture and sell reagents used for tests.

As of 11/30/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Diagnostics & Research
Index country:  USA
Country of incorporation:  USA
IPO date:  07/12/2017
Outstanding shares:  28,889,890
Average volume:  648,726
Market cap:   $276,187,348
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    189763105
ISIN:        US1897631057
Sedol:      BD3BX23
Valuation   (See tab for details)
PE ratio:   6.40
PB ratio:   2.68
PS ratio:   2.64
Return on equity:   41.90%
Net income %:   40.11%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy